TNGX vs. GEV
TNGX (Tango Therapeutics, Inc.) and GEV (GE Vernova Inc.) are both stocks. TNGX operates in Biotechnology (Healthcare), while GEV operates in Specialty Industrial Machinery (Industrials). Over the past year, TNGX returned 433.65% vs 107.61% for GEV. At a 0.14 correlation, their price movements are largely independent.
Performance
TNGX vs. GEV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TNGX achieves a 220.43% return, which is significantly higher than GEV's 58.65% return.
TNGX
- 1D
- -0.39%
- 1M
- 40.27%
- YTD
- 220.43%
- 6M
- 232.83%
- 1Y
- 433.65%
- 3Y*
- 96.53%
- 5Y*
- 20.02%
- 10Y*
- —
GEV
- 1D
- -8.21%
- 1M
- -0.31%
- YTD
- 58.65%
- 6M
- 56.76%
- 1Y
- 107.61%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
TNGX vs. GEV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
TNGX Tango Therapeutics, Inc. | 220.43% | 186.73% | -58.85% |
GEV GE Vernova Inc. | 58.65% | 99.02% | 186.24% |
Correlation
The correlation between TNGX and GEV is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (All Time) Calculated using the full available price history since Mar 27, 2024 | 0.14 |
Fundamentals
TNGX:
$4.08B
GEV:
$281.51B
TNGX:
-$0.89
GEV:
$34.12
TNGX:
59.93
GEV:
7.22
TNGX:
10.41
GEV:
20.22
TNGX:
$56.99M
GEV:
$39.38B
TNGX:
$55.33M
GEV:
$7.85B
TNGX:
-$111.92M
GEV:
$3.32B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TNGX vs. GEV — Risk / Return Rank
TNGX
GEV
TNGX vs. GEV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tango Therapeutics, Inc. (TNGX) and GE Vernova Inc. (GEV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TNGX | GEV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.21 | ||
| Sortino ratioReturn per unit of downside risk | +1.62 | ||
| Omega ratioGain probability vs. loss probability | 1.55 | 1.35 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | 14.95 | 4.40 | +10.55 |
| Martin ratioReturn relative to average drawdown | 38.53 | 12.77 | +25.76 |
Loading charts...
Drawdowns
TNGX vs. GEV - Drawdown Comparison
The maximum TNGX drawdown since its inception was -93.64%, which is greater than GEV's maximum drawdown of -38.29%. Use the drawdown chart below to compare losses from any high point for TNGX and GEV.
Loading charts...
Drawdown Indicators
| TNGX | GEV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.64% | -38.29% | -55.35% |
Max Drawdown (1Y)Largest decline over 1 year | -29.24% | -24.57% | -4.67% |
Max Drawdown (3Y)Largest decline over 3 years | -91.46% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -93.64% | — | — |
Current DrawdownCurrent decline from peak | -13.71% | -9.92% | -3.79% |
Average DrawdownAverage peak-to-trough decline | -47.81% | -7.01% | -40.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.32% | 8.45% | +2.87% |
Volatility
TNGX vs. GEV - Volatility Comparison
Tango Therapeutics, Inc. (TNGX) has a higher volatility of 50.81% compared to GE Vernova Inc. (GEV) at 17.74%. This indicates that TNGX's price experiences larger fluctuations and is considered to be riskier than GEV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TNGX | GEV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 50.81% | 17.74% | +33.07% |
Volatility (6M)Calculated over the trailing 6-month period | 79.15% | 34.20% | +44.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 100.42% | 50.61% | +49.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 102.22% | 54.00% | +48.22% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 96.03% | 54.00% | +42.03% |
Dividends
TNGX vs. GEV - Dividend Comparison
TNGX has not paid dividends to shareholders, while GEV's dividend yield for the trailing twelve months is around 0.19%.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
GEV GE Vernova Inc. | 0.19% | 0.11% | 0.08% |
TNGX Tango Therapeutics, Inc. | 0.00% | 0.00% | 0.00% |
Financials
TNGX vs. GEV - Financials Comparison
This section allows you to compare key financial metrics between Tango Therapeutics, Inc. and GE Vernova Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
TNGX and GEV have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TNGX has higher volatility (50.81%) compared to GEV (17.74%). In terms of maximum drawdown, TNGX dropped -93.64% vs GEV's -38.29%.
TNGX currently has the higher Sharpe Ratio (4.36 vs 2.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TNGX and GEV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer